BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8176207)

  • 1. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
    Oukka M; Riché N; Kosmatopoulos K
    J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
    J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
    Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA
    J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1989 Nov; 143(9):3007-14. PubMed ID: 2478631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza-specific cytotoxic T-cell recognition is inhibited by peptides unrelated in both sequence and MHC restriction.
    Bodmer HC; Bastin JM; Askonas BA; Townsend AR
    Immunology; 1989 Feb; 66(2):163-9. PubMed ID: 2466767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
    Beauverger P; Chadwick J; Buckland R; Wild TF
    Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
    Cole GA; Hogg TL; Coppola MA; Woodland DL
    J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo administration of major histocompatibility complex class I-specific peptides from influenza virus induces specific cytotoxic T cell hyporesponsiveness.
    Müllbacher A; Tha Hla R
    Eur J Immunol; 1993 Oct; 23(10):2526-31. PubMed ID: 8405053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes.
    Vitiello A; Heath WR; Sherman LA
    J Immunol; 1989 Sep; 143(5):1512-7. PubMed ID: 2474602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dominant Th epitope in influenza nucleoprotein. Analysis of the fine specificity and functional repertoire of T cells recognizing a single determinant.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1990 Apr; 144(7):2730-7. PubMed ID: 1690775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope.
    Deckhut AM; Allan W; McMickle A; Eichelberger M; Blackman MA; Doherty PC; Woodland DL
    J Immunol; 1993 Sep; 151(5):2658-66. PubMed ID: 7689611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide.
    Staerz UD; Zepp F; Schmid R; Hill M; Rothbard J
    Eur J Immunol; 1989 Dec; 19(12):2191-6. PubMed ID: 2481586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.